Intravitreal VEGF and bFGF produce florid retinal neovascularization and hemorrhage in the rabbit

Current Eye Research

Volumn 22, Issue 2, 2001, Pages 140-147

  Wong, C G ^a   Rich, K A ^a   Liaw, L H L ^a   Hsu, H T ^a   Berns, M W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Animal model; Basic fibroblast growth factor; Hemorrhage; Retinal neovascularization; Vascular endothelial growth factor

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; BOVINE SERUM ALBUMIN; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENUCLEATION; FLUORESCENCE ANGIOGRAPHY; IMPLANTATION; MALE; MICROSCOPY; NONHUMAN; OPHTHALMOSCOPY; OPTIC DISK; PHOTOGRAPHY; PRIORITY JOURNAL; RABBIT; RETINA BLOOD VESSEL; RETINA DETACHMENT; RETINA HEMORRHAGE; RETINA NEOVASCULARIZATION; VASODILATATION;

ANIMALS; DELAYED-ACTION PREPARATIONS; DRUG COMBINATIONS; DRUG IMPLANTS; ENDOTHELIAL GROWTH FACTORS; FIBROBLAST GROWTH FACTOR 2; FLUORESCEIN ANGIOGRAPHY; FUNDUS OCULI; LYMPHOKINES; MALE; OPHTHALMOSCOPY; RABBITS; RETINAL DETACHMENT; RETINAL HEMORRHAGE; RETINAL NEOVASCULARIZATION; RETINAL VESSELS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS; VITREOUS BODY;

EID: 0034819071     PISSN: 02713683     EISSN: None     Source Type: Journal    
DOI: 10.1076/ceyr.22.2.140.5528     Document Type: Article

References (43)

1. The vascular response to disease and photocoagulation
2. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization
3. Blindness caused by diabetic retinopathy
4. Clinical and experimental studies on retinal neovascularization. XXXIX Edward Jackson Memorial Lecture
5. Anterior hyaloidal fibrovascular proliferation after diabetic vitrectomy
6. Cryotherapy for active retinopathy of prematurity
7. Argon laser scatter photocoagulation for prevention of neovascularization and vitreous hemorrhage in branch vein occlusion. A randomized clinical trial
8. Diabetic Retinopathy Vitrectomy Study Report 2. Early vitrectomy for severe vitreous hemorrhage in diabetic retinopathy. Two-year results of a randomized trial
9. Treatment of macular degeneration, according to Bangerter
10. Age-related macular degeneration and risk factors for the development of choroidal neovascularization in the fellow eye
11. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy
12. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders
13. Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases
14. Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor
15. Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes
16. Levels of vascular endothelial growth factor are elevated in the vitreous of patients with subretinal neovascularisation
17. Vascular endothelial growth factor is a potential tumor angiogenesis factor in human gliomasin vivo
18. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogensis
19. Inhibition of proliferative retinopathy using antisense phosphorothioate oligonucleotides against vascular endothelial growth factor
20. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins
21. Oligodeoxynucleotides inhibit retinal neovascularization in a murine model of proliferative retinopathy
22. Vascular endothelial growth factor is sufficient to produce ocular neovascularization
23. Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate
24. Intravitreal sustained release of VEGF causes retinal neovascularization in rabbits and breakdown of the blood-retinal barrier in rabbits and primates
25. Mechanisms of retinal and choroidal neovascularization
26. Basic fibroblast growth factor levels in the vitreous of patients with proliferative diabetic retinopathy
27. Basic fibroblast growth factor and vascular endothelial growth factor are present in epiretinal and choroidal neovascular membranes
28. Retinal degeneration in transgenic mice with photoreceptor-specific expression of a dominant-negative fibroblast growth factor receptor
29. Basic fibroblast growth factor and local injury protect photoreceptors from light damage in the rat
30. Basic fibroblast growth factor (bFGF) immuno-localization in the rodent outer retina demonstrated with anti-rodent bfgf antibodies
31. A gradient of basic fibroblast growth factor in rod photoreceptors in the normal human retina
32. Basic fibroblast growth factor is neither necessary nor sufficient for the development of retinal neovascularization
33. An experimental model of preretinal neovascularization in the rabbit
34. Retinal vessel dilatation and elongation precedes diabetic macular oedema
35. Retinal vasoconstriction after laser treatment for diabetic macular edema
36. Optical doppler tomography: Imaging in vivo blood flow dynamics following pharmacological intervention and photodynamic therapy
37. Muller cells in vascular and avascular retinae: A survey of seven mammals
38. Antigenic changes of rabbit retinal Muller cells in culture
39. On the pathogenesis of diabetic retinopathy
40. Pigment epithelium-derived factor: A potent inhibitor of angiogenesis
41. PEDF: A pigment epithelium-derived factor with potent neuronal differentiative activity
42. Pigment epithelium-derived factor: Neutrophic activity and identification as a member of the serine protease inhibitor gene family